metformin and dinoprost
metformin has been researched along with dinoprost in 14 studies
Research
Studies (14)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 10 (71.43) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Belgorosky, D; Elia, EM; Faut, M; Luigi, D; Motta, AB; Pustovrh, C; Vighi, S | 1 |
Facorro, GB; Motta, AB; Piehl, L; Rubín de Celis, E; Sander, VA | 1 |
Colette, C; Cristol, JP; Michel, F; Monnier, L; Owens, DR | 1 |
Benarroch, M; Gornitsky, M; Salah, MH; Schipper, HM; Su, H; Trifiro, M; Velly, AM | 1 |
Lee, IT; Lee, WJ; Lin, SD; Lin, SY; Sheu, WH; Su, SL; Tseng, YH; Tu, ST; Wang, JS | 1 |
Hou, WK; Huang, QX; Li, MZ; Lin, P; Liu, Q; Song, J; Wang, K; Wang, Q; Xu, H; Yu, S; Zhang, L; Zhang, Y | 1 |
Crea, F; Di Franco, A; Ghirlanda, G; Lanza, GA; Manto, A; Milo, M; Nerla, R; Pagliaccia, F; Pitocco, D; Rizzo, P; Rocca, B; Scavone, G; Tarzia, P; Zaccardi, F | 1 |
Aslan, I; Aslan, M; Tuzcu, H | 1 |
Poretsky, L; Striker, GE; Vlassara, H; Woodward, M; Yubero-Serrano, EM | 1 |
Nurifahmi, R; Sauriasari, R; Sekar, AP; Susilo, VY; Wulandari, F | 1 |
Hur, KY; Jin, SM; Kim, G; Kim, JH; Lee, MK; Oh, S | 1 |
Andreadou, I; Dimopoulos, MA; Doerschmann, H; Efentakis, P; Kastritis, E; Nikolaou, PE; Siemer, S; Stauber, R; Terpos, E; Wenzel, P; Witzler, C | 1 |
Trials
5 trial(s) available for metformin and dinoprost
Article | Year |
---|---|
Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
Topics: Acarbose; Adult; Aged; Biomarkers; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dinoprost; Drug Therapy, Combination; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Lipoproteins, LDL; Male; Medication Adherence; Metformin; Middle Aged; Outpatients; Oxidative Stress; Regression Analysis; Taiwan; Time Factors; Treatment Outcome | 2011 |
Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients.
Topics: Apelin; Blood Glucose; Body Mass Index; Chemokines; Diabetes Mellitus, Type 2; Dinoprost; Humans; Hypoglycemic Agents; Inflammation; Intercellular Signaling Peptides and Proteins; Metformin; Pioglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2012 |
Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study.
Topics: Adult; Biomarkers; Blood Glucose; Brachial Artery; Diabetes Mellitus, Type 1; Dinoprost; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Oxidative Stress; Pilot Projects; Treatment Outcome; Vasodilation | 2013 |
Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.
Topics: Adiponectin; Age Factors; Aged; Albuminuria; Chelating Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Estrogen Receptor alpha; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Intention to Treat Analysis; Lysine; Male; Metformin; Middle Aged; NF-E2-Related Factor 2; Pyruvaldehyde; Receptor for Advanced Glycation End Products; Receptors, Tumor Necrosis Factor, Type I; RNA, Messenger; Sevelamer; Sex Factors; Single-Blind Method; Sirtuin 1; White People | 2015 |
The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus.
Topics: Adamantane; Blood Glucose; Diabetes Mellitus, Type 2; Dinoprost; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Nitriles; Pyrrolidines; Sulfonylurea Compounds; Treatment Outcome; Vildagliptin | 2017 |
Other Studies
9 other study(ies) available for metformin and dinoprost
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
The effects of metformin on uterine tissue of hyperandrogenized BALB/c mice.
Topics: Animals; Blotting, Western; Catalase; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclooxygenase 2; Dehydroepiandrosterone; Dinoprost; Enzyme Activation; Female; Flow Cytometry; In Vitro Techniques; Metformin; Mice; Mice, Inbred BALB C; Nitric Oxide Synthase; Oxidative Stress; Polycystic Ovary Syndrome; Radioimmunoassay; Superoxide Dismutase; Uterus | 2009 |
Effect of DHEA and metformin on corpus luteum in mice.
Topics: Animals; Corpus Luteum; Dehydroepiandrosterone; Dinoprost; Female; Hyperandrogenism; Hypoglycemic Agents; Lipid Peroxidation; Metformin; Mice; Mice, Inbred BALB C; Ovary; Oxidative Stress; Pregnancy; Prostaglandins E | 2009 |
Insulin therapy has a complex relationship with measure of oxidative stress in type 2 diabetes: a case for further study.
Topics: Aged; Body Mass Index; Caloric Restriction; Diabetes Mellitus, Type 2; Dinoprost; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Oxidative Stress; Reproducibility of Results; Thiazolidinediones | 2011 |
Altered redox homeostasis in human diabetes saliva.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Age Factors; Biomarkers; Deoxyguanosine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diet, Diabetic; Dinoprost; DNA Damage; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Metformin; Oxidation-Reduction; Oxidative Stress; Protein Carbonylation; Saliva; Salivary Proteins and Peptides; Sex Factors | 2012 |
The effect of high-dose insulin analog initiation therapy on lipid peroxidation products and oxidative stress markers in type 2 diabetic patients.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Dinoprost; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Insulin; Lipid Peroxidation; Male; Metformin; Middle Aged; Nitrates; Nitrites; Oxidative Stress; Protein Carbonylation; Sulfonylurea Compounds; Tyrosine | 2013 |
The Correlation Between Urinary 8-Iso-Prostaglandin F2α and Hydrogen Peroxide Toward Renal Function in T2DM Patients Consuming Sulfonylurea and Combination of Metformin-Sulfonylurea.
Topics: Aged; Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Female; Glomerular Filtration Rate; Humans; Hydrogen Peroxide; Hypoglycemic Agents; Linear Models; Male; Metformin; Middle Aged; Oxidative Stress; Sulfonylurea Compounds | 2018 |
Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib.
Topics: Actins; AMP-Activated Protein Kinase Kinases; Animals; Antineoplastic Agents; Autophagy; Cell Survival; Cobalt; Dinoprost; Drug Therapy, Combination; Endoplasmic Reticulum; Glucose; Glycolysis; Humans; Male; Metformin; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; Nitric Oxide; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Kinases; Reactive Oxygen Species; Tumor Suppressor Protein p53 | 2020 |